Exclusive rights to distribute CE-IVD marked Dragonfly diagnostic system in key client segments.Dragonfly System able to detect five common respiratory pathogens at once. LONDON, UK, January 09, 2023 / B3C newswire / ProtonDx, an in vitro diagnostic company designing, manufacturing and marketing rapid.
ProtonDx Awarded £365,000 Defra and Innovate UK Grant ProtonDx Ltd, an Imperial College health technology spin-out company delivering cost-effective, ultra-rapid, accurate and portable molecular testing, has been awarded a £365,000 grant from Defra’s Farming Innovation Programme and UKRI’s Transforming Food Production Challenge (Innovate UK) to develop rapid, accurate, point-of-care tests for porcine lung diseases, in collaboration with Imperial College London. Click to read more.
Grant to develop automated, rapid point-of-need diagnostic to provide a sustainable and resilient revolution in detection and diagnosis of Porcine Respiratory Disease Complex (PRDC)Working in collaboration with Imperial College, farmers and industry experts to help address the global issue of rising antibiotic resis.
5-in-1 Respiratory Test Panel used to assess elite athletes LONDON, UK, August 31, 2022 / B3C newswire / Today, ProtonDx, a health technology company developing robust, point-of-need diagnostic solutions, announced that Dragonfly™, its portable, rapid diagnostic system, formed a key part of the diagnostic testing.